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CORRECTIONS
The publisher apologizes for the omission of the following abstracts from the September 2003 issue of the Journal:
In: Bedside intravascular ultrasound-guided vena cava filter placement. (Wellons ED, Matsuura JH, Shuler FW, Franklin JS,
Rosenthal D. J Vasc Surg 2003;38:455-8).
Objective: Several reports have demonstrated the efficacy of inferior vena cava filter (IVCF) placement with intravascular ultrasound
guidance (IVUS). The majority of these procedures, however, have been done in concert with contrast venography and/or
fluoroscopic guidance. The purpose of this report was to evaluate the potential for bedside IVCF placement with “real-time” IVUS
guidance only.
Design of study: In a phase I trial, 10 patients underwent IVUS interrogation of the IVC for diameter measurements and
localization of the renal veins. Contrast venography verified the IVUS findings prior to filter deployment. In a phase II trial,
another 35 patients underwent intensive care unit bedside placement of an IVC filter with only “real-time” IVUS guidance using
a double puncture technique in the same femoral vein. All patients underwent color-flow ultrasonography of the femoral veins
after filter placement to rule out postprocedure femoral vein thrombosis and plain radiographs of the abdomen to identify filter
location.
Results: In the phase I trial, all filters were placed within 15 mm of the most inferior renal vein identified by IVUS. There were no
complications, and successful filter placement was verified by contrast venography. In phase II, 33 IVCFs were placed without
complications at approximately the L2 level by plain radiograph. One patient had an IVCF deployed in the common iliac vein,
which necessitated placement of an uneventful second IVCF at the infrarenal location by IVUS. This same patient had a femoral
deep venous thrombosis identified by postoperative duplex ultrasonography. A second patient had IVC thrombus identified by
IVUS, and placement was performed with contrast venography in the fluoroscopy suite. IVC measurements ranged from 18-28
mm in diameter.
Conclusions: IVUS accurately measures the IVC diameter and localizes the renal veins, allowing for exact placement of IVCFs.
IVUS further avoids the need for contrast agents and for transport of critically ill patients. Bedside insertion of an IVCF with IVUS
guidance is simple, safe, and accurate. Further assessment of this technique is warranted.
In: “Secondary conversion due to failed endovascular abdominal aortic aneurysm repair” (Terramani TT, Chaikof EL,
Rayan SS, Lin PH, Najibi S, Bush RL, et al. J Vasc Surg 2003;38:473-8)
Purpose: Endovascular repair of infrarenal abdominal aortic aneurysms (AAA) is associated with a risk of late treatment failure due
to persistent endoleak, aneurysm enlargement, infection, loss of device integrity, or graft thrombosis. This report describes our
experience with secondary conversion (delayed explantation) of failed infrarenal AAA endografts.
Patients and methods: During an eight-year period, a total of 319 patients underwent infrarenal AAA endovascular repair. Of these,
nine (2.8%) patients underwent secondary conversion to open surgical repair following endovascular repair. The time interval
between endograft placement and secondary conversion was 24  13 months (range, 2-48 months).
Results: The indications for secondary conversion were endograft infection (n 1), aortic aneurysm enlargement (5 mm) with
(n 6) or without endoleak (n 2). Explanted endografts included the following devices: Excluder (WL Gore, n 1), AneuRx
(Medtronic AVE, n  1), and Ancure/EVT tube (Guidant, n  7). All patients underwent successful aortic bypass grafting
following endograft removal. Mean follow-up after conversion was 29  28 months (range, 4-72 months). Due to variations in
device design, a range of operative techniques were used to facilitate endograft explantation. Removal of Ancure/EVT tube and
Excluder endografts necessitated suprarenal aortic clamping in order to facilitate circumferential detachment of the proximal
endograft hooks and barbs. In addition, explant procedures were assisted by cooling of AneuRx and Excluder endografts with iced
saline so as to contract the Nitinol stent scaffold. The method of aortic reconstruction was aortobiiliac (n 7), aortouniiliac (n
1), and axillobifemoral (n  1). The postoperative length of stay was 20  21 days (range, 7-70 days) and associated morbidity
included non–Q wave myocardial infarction (n 1), respiratory failure requiring reintubation (n 1), endocarditis (n 1), and
urinary tract infection (n  2). Thirty-day perioperative mortality was 11% (1/9).
Conclusion: Despite the overall high technical and clinical success rates of endovascular AAA repair, the risk of late failure remains.
Unique challenges are associated with removal of aortic endografts and preoperative planning requires careful consideration of
distinct differences among endograft designs. Physicians should be aware of these modes of failure and the technical details to
intervene on the failed endograft.
In: “Endovascular treatment of carotid stump syndrome” (Naylor AR, Bell PR, Bolia A. J Vasc Surg 2003;38:593-5)
Carotid stump syndrome is a rare cause of transient ischemic attacks/stroke and is usually treated by open surgery and exclusion
of the stump from the circulation. An alternative method for treatment, deploying a covered stent to exclude the stump, was
successfully utilized in a highly symptomatic patient who had previously undergone carotid endarterectomy. Endovascular
exclusion of the symptomatic carotid stump is an alternative to operative surgery.
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